Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Dammes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|September 7, 2020
Paving the Road for RNA TherapeuticsNiels Dammes, Dan Peer
Theranostics|January 7, 2020
Monoclonal antibody-based molecular imaging strategies and theranostic opportunitiesNiels Dammes, Dan Peer
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2019
Therapeutic mRNA delivery to leukocytesYasmin Granot-Matok, Edo Kon, Niels Dammes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Current Progress in Non-viral RNAi-Based Delivery Strategies to LymphocytesShoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 31, 2020
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to LeukocytesSrinivas Ramishetti, Inbal Hazan-Halevy, Ramesh Palakuri, et al.
ACS Nano|January 22, 2021
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered <i>via</i> Lipid NanoparticlesUri Elia, Srinivas Ramishetti, Ronit Rosenfeld, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|September 7, 2020
Paving the Road for RNA TherapeuticsNiels Dammes, Dan Peer
Theranostics|January 7, 2020
Monoclonal antibody-based molecular imaging strategies and theranostic opportunitiesNiels Dammes, Dan Peer
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2019
Therapeutic mRNA delivery to leukocytesYasmin Granot-Matok, Edo Kon, Niels Dammes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Current Progress in Non-viral RNAi-Based Delivery Strategies to LymphocytesShoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 31, 2020
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to LeukocytesSrinivas Ramishetti, Inbal Hazan-Halevy, Ramesh Palakuri, et al.
ACS Nano|January 22, 2021
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered <i>via</i> Lipid NanoparticlesUri Elia, Srinivas Ramishetti, Ronit Rosenfeld, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Pageof 1